BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21725814)

  • 21. Beneficial use of Cetaphil moisturizing cream as part of a daily skin care regimen for individuals with rosacea.
    Laquieze S; Czernielewski J; Baltas E
    J Dermatolog Treat; 2007; 18(3):158-62. PubMed ID: 17538804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced skin localization of metronidazole using solid lipid microparticles incorporated into polymeric hydrogels for potential improved of rosacea treatment: An ex vivo proof of concept investigation.
    Sulistiawati ; Saka Dwipayanti K; Azhar M; Rahman L; Pakki E; Himawan A; Permana AD
    Int J Pharm; 2022 Nov; 628():122327. PubMed ID: 36280218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formulation development of physiological environment responsive periodontal drug delivery system for local delviery of metronidazole benzoate.
    Dabhi MR; Sheth NR
    Drug Dev Ind Pharm; 2013 Mar; 39(3):425-36. PubMed ID: 22393879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chitosan and a modified chitosan as agents to improve performances of mucoadhesive vaginal gels.
    Perioli L; Ambrogi V; Venezia L; Pagano C; Ricci M; Rossi C
    Colloids Surf B Biointerfaces; 2008 Oct; 66(1):141-5. PubMed ID: 18621512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimisation of polyherbal gels for vaginal drug delivery by Box-Behnken statistical design.
    Chopra S; Motwani SK; Iqbal Z; Talegaonkar S; Ahmad FJ; Khar RK
    Eur J Pharm Biopharm; 2007 Aug; 67(1):120-31. PubMed ID: 17270408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Examination of the flow rheological and textural properties of polymer gels composed of poly(methylvinylether-co-maleic anhydride) and poly(vinylpyrrolidone): rheological and mathematical interpretation of textural parameters.
    Jones DS; Lawlor MS; Woolfson AD
    J Pharm Sci; 2002 Sep; 91(9):2090-101. PubMed ID: 12210055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of colloidal silicon dioxide on gel strength, robustness, and adhesive properties of diclofenac gel formulation for topical application.
    Lu Z; Fassihi R
    AAPS PharmSciTech; 2015 Jun; 16(3):636-44. PubMed ID: 25501873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of skin barrier function in rosacea patients with a novel 1% metronidazole gel.
    Draelos ZD
    J Drugs Dermatol; 2005; 4(5):557-62. PubMed ID: 16167413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In situ gelling xyloglucan/alginate liquid formulation for oral sustained drug delivery to dysphagic patients.
    Itoh K; Tsuruya R; Shimoyama T; Watanabe H; Miyazaki S; D'Emanuele A; Attwood D
    Drug Dev Ind Pharm; 2010 Apr; 36(4):449-55. PubMed ID: 19788404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Managing rosacea: a review of the use of metronidazole alone and in combination with oral antibiotics.
    Conde JF; Yelverton CB; Balkrishnan R; Fleischer AB; Feldman SR
    J Drugs Dermatol; 2007 May; 6(5):495-8. PubMed ID: 17679183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cumulative irritation potential of metronidazole gel compared to azelaic acid gel after repeated applications to healthy skin.
    Ziel K; Yelverton CB; Balkrishnan R; Feldman SR
    J Drugs Dermatol; 2005; 4(6):727-31. PubMed ID: 16302558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical metronidazole. A review of its use in rosacea.
    McClellan KJ; Noble S
    Am J Clin Dermatol; 2000; 1(3):191-9. PubMed ID: 11702300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of topical azelaic acid (AzA) gel 15% plus oral doxycycline 40 mg versus metronidazole gel 1% plus oral doxycycline 40 mg in mild-to-moderate papulopustular rosacea.
    Del Rosso JQ; Bruce S; Jarratt M; Menter A; Staedtler G
    J Drugs Dermatol; 2010 Jun; 9(6):607-13. PubMed ID: 20645521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thermoresponsive fluconazole gels for topical delivery: rheological and mechanical properties, in vitro drug release and anti-fungal efficacy.
    Gandra SC; Nguyen S; Nazzal S; Alayoubi A; Jung R; Nesamony J
    Pharm Dev Technol; 2015 Jan; 20(1):41-9. PubMed ID: 24160864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of an emulgel for the treatment of rosacea using quality by design approach.
    Torregrosa A; Ochoa-Andrade AT; Parente ME; Vidarte A; Guarinoni G; Savio E
    Drug Dev Ind Pharm; 2020 Feb; 46(2):296-308. PubMed ID: 31944126
    [No Abstract]   [Full Text] [Related]  

  • 36. Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea.
    Dahl MV; Jarratt M; Kaplan D; Tuley MR; Baker MD
    J Am Acad Dermatol; 2001 Nov; 45(5):723-30. PubMed ID: 11606923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In situ forming implants for the delivery of metronidazole to periodontal pockets: formulation and drug release studies.
    Kilicarslan M; Koerber M; Bodmeier R
    Drug Dev Ind Pharm; 2014 May; 40(5):619-24. PubMed ID: 24369747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Textural analysis and flow rheometry of novel, bioadhesive antimicrobial oral gels.
    Jones DS; Woolfson AD; Brown AF
    Pharm Res; 1997 Apr; 14(4):450-7. PubMed ID: 9144730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-inflamatory dose doxycycline in the treatment of rosacea.
    Del Rosso JQ
    J Drugs Dermatol; 2009 Jul; 8(7):664-8. PubMed ID: 19588643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel aqueous metronidazole 1% gel with hydrosolubilizing agents (HSA-3).
    Dow G; Basu S
    Cutis; 2006 Apr; 77(4 Suppl):18-26. PubMed ID: 16706246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.